Home / Business and Economy / Pharma Expansion Approved in Bengaluru
Pharma Expansion Approved in Bengaluru
16 May
Summary
- Government approves Unit II expansion project in Bengaluru.
- Expansion aims to boost manufacturing for global partners.
- Company posted a decline in net profit for Q4.
Onesource Specialty Pharma Ltd. announced on Saturday, May 16, 2026, that it has secured government approval for an expansion project at its Unit II facility in Bengaluru. This approval is a crucial step in the company's strategic plan to enhance its manufacturing capacity.
The expansion of Unit II, described as a flagship facility, is intended to better serve the company's global partners. This move signifies a commitment to growth and increased operational scale.
However, the company's recent financial report for the fourth quarter indicated a notable decrease in consolidated net profit compared to the previous year, despite a slight rise in revenue. EBITDA also saw a significant reduction, and the EBITDA margin contracted considerably.
In terms of market performance, shares of Onesource Specialty Pharma Ltd. experienced a modest increase in the last trading session, following a more substantial gain over the past month.
